These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10718489)

  • 1. Symptoms associated with oophorectomy and tamoxifen treatment for breast cancer in premenopausal Vietnamese women.
    Love RR; Nguyen BD; Nguyen CB; Nguyen VD; Havighurst TC
    Breast Cancer Res Treat; 1999 Dec; 58(3):281-6. PubMed ID: 10718489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer.
    Love RR; Duc NB; Allred DC; Binh NC; Dinh NV; Kha NN; Thuan TV; Mohsin SK; Roanh le D; Khang HX; Tran TL; Quy TT; Thuy NV; Thé PN; Cau TT; Tung ND; Huong DT; Quang le M; Hien NN; Thuong L; Shen TZ; Xin Y; Zhang Q; Havighurst TC; Yang YF; Hillner BE; DeMets DL
    J Clin Oncol; 2002 May; 20(10):2559-66. PubMed ID: 12011136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
    Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
    J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.
    Love RR; Young GS; Laudico AV; Van Dinh N; Uy GB; Quang le H; De La Peña AS; Dofitas RB; Bisquera OC; Siguan SS; Salvador JD; Mirasol-Lumague MR; Navarro NS; Linh ND; Jarjoura D
    Cancer; 2013 Nov; 119(21):3746-52. PubMed ID: 23963821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.
    Love RR; Hossain SM; Hussain MM; Mostafa MG; Laudico AV; Siguan SS; Adebamowo C; Sun JZ; Fei F; Shao ZM; Liu Y; Akram Hussain SM; Zhang B; Cheng L; Panigaro S; Walta F; Chuan JH; Mirasol-Lumague MR; Yip CH; Navarro NS; Huang CS; Lu YS; Ferdousy T; Salim R; Akhter C; Nahar S; Uy G; Young GS; Hade EM; Jarjoura D
    Eur J Cancer; 2016 Jun; 60():107-16. PubMed ID: 27107325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
    Bernhard J; Luo W; Ribi K; Colleoni M; Burstein HJ; Tondini C; Pinotti G; Spazzapan S; Ruhstaller T; Puglisi F; Pavesi L; Parmar V; Regan MM; Pagani O; Fleming GF; Francis PA; Price KN; Coates AS; Gelber RD; Goldhirsch A; Walley BA
    Lancet Oncol; 2015 Jul; 16(7):848-58. PubMed ID: 26092816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor-Positive Breast Cancer: A Global Treatment Option.
    Love RR
    Clin Breast Cancer; 2016 Aug; 16(4):233-7. PubMed ID: 27117241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
    Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
    Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms.
    Nystedt M; Berglund G; Bolund C; Brandberg Y; Fornander T; Rutqvist LE
    Acta Oncol; 2000; 39(8):959-68. PubMed ID: 11207003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.
    Buchanan RB; Blamey RW; Durrant KR; Howell A; Paterson AG; Preece PE; Smith DC; Williams CJ; Wilson RG
    J Clin Oncol; 1986 Sep; 4(9):1326-30. PubMed ID: 3528402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.
    Love RR; Laudico AV; Van Dinh N; Allred DC; Uy GB; Quang le H; Salvador JD; Siguan SS; Mirasol-Lumague MR; Tung ND; Benjaafar N; Navarro NS; Quy TT; De La Peña AS; Dofitas RB; Bisquera OC; Linh ND; To TV; Young GS; Hade EM; Jarjoura D
    J Natl Cancer Inst; 2015 Jun; 107(6):djv064. PubMed ID: 25794890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer.
    Love RR; Duc NB; Havighurst TC; Mohsin SK; Zhang Q; DeMets DL; Allred DC
    J Clin Oncol; 2003 Feb; 21(3):453-7. PubMed ID: 12560434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.
    Ingle JN; Krook JE; Green SJ; Kubista TP; Everson LK; Ahmann DL; Chang MN; Bisel HF; Windschitl HE; Twito DI
    J Clin Oncol; 1986 Feb; 4(2):178-85. PubMed ID: 3511184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young age as an adverse prognostic factor in premenopausal women with operable breast cancer.
    Love RR; Duc NB; Dinh NV; Quy TT; Xin Y; Havighurst TC
    Clin Breast Cancer; 2002 Jan; 2(4):294-8. PubMed ID: 11899361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study.
    Hughes LL; Gray RJ; Solin LJ; Robert NJ; Martino S; Tripathy D; Ingle JN; Wood WC; ; ; ;
    Cancer; 2004 Sep; 101(5):969-72. PubMed ID: 15329905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study.
    Love RR; Ba Duc N; Cong Binh N; Mahler PA; Thomadsen BR; Hong Long N; Shen TZ; Havighurst TC
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):697-703. PubMed ID: 12788175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
    Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?
    Thewes B; Meiser B; Duric VM; Stockler MR; Taylor A; Stuart-Harris R; Links M; Wilcken N; McLachlan SA; Phillips KA; Beith J; Boyle F; Friedlander ML
    Lancet Oncol; 2005 Aug; 6(8):581-8. PubMed ID: 16054569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.